BARR PHARMACEUTICALS INC 4
4 · BARR PHARMACEUTICALS INC · Filed Dec 29, 2008
Insider Transaction Report
Form 4
SEAVER PETER
Director
Transactions
- Disposition to Issuer
Non-Qualified Stock Options
2008-12-23−10,000→ 0 totalExercise: $57.35From: 2006-11-03Exp: 2015-11-03→ Common Stock (10,000 underlying) - Disposition to Issuer
Non-Qualified Stock Options
2008-12-23−5,000→ 0 totalExercise: $54.25From: 2008-05-17Exp: 2017-05-17→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]These options were assumed by Teva Pharmaceutical Industries Ltd pursuant to a merger agreement between the Issuer and Teva and replaced with options to purchase 15,812 shares of Teva Common Stock for $36.27 per share.
- [F2]These options were assumed by Teva Pharmaceutical Industries Ltd pursuant to a merger agreement between the Issuer and Teva and replaced with options to purchase 7,906 shares of Teva Common Stock for $34.31 per share.